-
Pfizer Takes Aim at Johnson & Johnson
Post on 9/12/16
-
Cancer Genetics Announces $5.5 Million Registered Direct Offering
Post on 9/9/16
-
Is Pfizer About to Slash Its Dividend?
Post on 9/9/16
-
Merck & Co's (MRK) Management Presents at Wells Fargo Healthcare Conference
Post on 9/9/16
-
Johnson & Johnson (JNJ) Management Presents at Wells Fargo Securities Research, Economics & Strategy 2016 Healthcare Conference - Transcript
Post on 9/9/16
-
Johnson & Johnson - How To Quit Working In 8 Years With $1.5M In Savings
Post on 9/9/16
-
Amsterdam Dental Group Holds Open House at its Newly Expanded and Renovated Office in Paoli, PA
Post on 9/7/16
-
Outlaw Training and Fitness Celebrates its 5th Year Anniversary with a Community Night Out
Post on 9/7/16
-
September is National Rheumatic Disease Awareness Month
Post on 9/7/16
-
The Children's Hospital of Philadelphia Announces Philadelphia Insurance Companies as Sponsor of 2016 Parkway Run & Walk
Post on 9/1/16
-
Neptune City Mayor Visits Coral Harbor Rehabilitation and Healthcare Center
Post on 9/1/16
-
3 Clinical-Stage Biotech Stocks With News About To Break
Post on 9/1/16
-
Could Pfizer Face An Apple-Like Tax Surprise in the EU?
Post on 8/31/16
-
MedyMatch Announces Leading Physicians Join the MedyMatch Scientific and Medical Advisory Board
Post on 8/30/16
-
Vention Medical Expands Presence in Ireland
Post on 8/30/16
-
The Medicines Company Provides Update on Dyslipidemia Programs
Post on 8/30/16
-
Steri-Clean Franchise Coming to Pittsburgh Metropolitan
Post on 8/30/16
-
Better Buy: GlaxoSmithKline plc vs. AbbVie
Post on 8/30/16
-
Medical Guardian Named in Philadelphia Business Journal’s Best Places to Work
Post on 8/29/16
-
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)
Post on 8/29/16
-
3 Reasons Celldex Therapeutics, Inc. Stock Could Fall
Post on 8/29/16
-
Billionaire George Soros' Fund Dumped These 3 Biotech Holdings. Should You?
Post on 8/29/16
-
4 Stocks That Billionaires Wanted Little to Do With in the Second Quarter
Post on 8/29/16
-
A Merck Versus Bristol Showdown
Post on 8/29/16
-
Antares Pharmaceuticals: The Stock To Buy On EpiPen Issues
Post on 8/29/16
Philadelphia
